Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DL

Daniel D. Long — 104 Patents

THTheravance: 60 patents #5 of 116Top 5%
TITheravance Biopharma R&D Ip: 42 patents #3 of 116Top 3%
San Francisco, CA: #129 of 26,999 inventorsTop 1%
California: #2,097 of 386,348 inventorsTop 1%
Overall (All Time): #13,407 of 4,157,543Top 1%
104 Patents All Time
Daniel D. Long has been granted 104 US patents while listed as an inventor at Theravance. The first was granted in 2005 and the most recent in August 2025. Daniel D. Long ranks #13,407 of 4,157,543 US inventors in our database (top 0.32%). Patent records list Daniel D. Long in San Francisco, CA, US.

Issued Patents All Time

Showing 1–25 of 104 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12398135 Dimethyl amino azetidine amides as JAK inhibitors Cameron Smith, Corbin Thompson 2025-08-26
11919836 Prodrugs of fencamfamine Sandeep Patil, Ron Bihovsky, Steven A. Smith, YuHua Ji, Valentino J. Stella +1 more 2024-03-05
11845747 Ester and carbonate pyrimidine compounds as JAK kinase inhibitors Philip A. Gerken, Jianhua Chao 2023-12-19
11713315 5 to 7 membered heterocyclic amides as JAK inhibitors Cameron Smith, Corbin Thompson 2023-08-01
11634419 Dimethyl amino azetidine amides as JAK inhibitors Cameron Smith, Corbin Thompson 2023-04-25
11608354 Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease Ryan Hudson, Donna A. A. Wilton, Mandy Loo, Patrick J. Brassil 2023-03-21
11548887 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists John R. Jacobsen, Lan Jiang 2023-01-10
11155549 Ester and carbonate pyrimidine compounds as JAK kinase inhibitors Philip A. Gerken, Jianhua Chao 2021-10-26
10961267 Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease Ryan Hudson, Donna A. A. Wilton, Mandy Loo, Patrick J. Brassil 2021-03-30
10947229 Dimethyl amino azetidine amides as JAK inhibitors Cameron Smith, Corbin Thompson 2021-03-16
10836763 5 to 7 membered heterocyclic amides as JAK inhibitors Cameron Smith, Corbin Thompson 2020-11-17
10745394 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists John R. Jacobsen, Lan Jiang, Ioanna Stergiades, Priscilla Van Dyke 2020-08-18
10745405 Glucuronide prodrugs of Janus kinase inhibitors Donna A. A. Wilton, Mandy Loo, Ryan Hudson, Patrick J. Brassil 2020-08-18
10662146 Prodrugs of fencamfamine Sandeep Patil, Ron Bihovsky, Steven A. Smith, YuHua Ji, Valentino J. Stella +1 more 2020-05-26
10472366 Glucuronide prodrugs of tofacitinib Donna A. A. Wilton, Mandy Loo 2019-11-12
10435428 Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory disease Ryan Hudson, Donna A. A. Wilton, Mandy Loo, Patrick J. Brassil 2019-10-08
10377751 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists John R. Jacobsen, Lan Jiang, Daisuke Saito, Ioanna Stergiades 2019-08-13
10233174 Thiocarbamate prodrugs of tofacitinib 2019-03-19
10081626 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists John R. Jacobsen, Lan Jiang 2018-09-25
10005740 Neprilysin inhibitors Melissa Fleury, Anne-Marie Beausoleil, Adam D. Hughes, Donna A. A. Wilton 2018-06-26
9873692 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists Daniel Marquess, Paul R. Fatheree, S. Derek Turner, Seok-Ki Choi, Adam A. Goldblum 2018-01-23
9839639 Neprilysin inhibitors Melissa Fleury, Anne-Marie Beausoliel, Adam D. Hughes, Donna A. A. Wilton 2017-12-12
9783507 Neprilysin inhibitors Melissa Fleury, Anne-Marie Beausoliel, Adam D. Hughes, Donna A. A. Wilton 2017-10-10
9669027 Hepatitis C virus inhibitors Robert Murray McKinnell, Lan Jiang, Mandy Loo, Kassandra Lepack, Lori Jean Van Orden +1 more 2017-06-06
9663509 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists John R. Jacobsen, Lan Jiang 2017-05-30